Uzedy is a long-acting injectable antipsychotic medication. It contains risperidone and is designed to be administered subcutaneously (under the skin), typically once every one or two months.
It is primarily used to treat:
- Schizophrenia
- Bipolar Disorder
Unlike daily oral medications, Uzedy provides a steady release of medication over time, which can help maintain more consistent symptom control.
What Is Uzedy Used For?
Uzedy is FDA-approved for:
- Schizophrenia in adults
While risperidone itself may be used in other contexts, Uzedy specifically is designed for schizophrenia management and long-term stability, especially for individuals who:
- Have difficulty staying consistent with daily medication
- Experience symptom relapse when stopping medication
- Benefit from structured, ongoing treatment
What Is Uzedy Made Of?
Uzedy is made up of an active medication and a delivery system that controls how it works in the body.
| Component | What It Is | What It Does | Why It Matters |
|---|---|---|---|
| Active Ingredient | Risperidone (atypical antipsychotic) | Helps regulate dopamine and serotonin in the brain | Reduces symptoms like hallucinations, delusions, and disorganized thinking |
| Extended-Release System | Subcutaneous depot delivery technology | Slowly releases medication over weeks or months after injection | Keeps medication levels steady and reduces the need for daily pills |
| Biocompatible Materials | Medical-grade polymers that break down safely in the body | Forms a small reservoir under the skin that dissolves over time | Allows controlled, predictable release of medication |
| Inactive Ingredients (Excipients) | Stabilizers and formulation agents | Support absorption, stability, and consistency | Ensures the medication works reliably and safely |
Simple Breakdown
- Risperidone is the part that treats symptoms
- The delivery system is what makes it long-acting
- Everything else helps it stay stable and release properly
How Uzedy Works in the Brain
Uzedy works by affecting neurotransmitters, especially dopamine and serotonin, which play a role in mood, perception, and thought patterns.
In simple terms:
- It helps reduce hallucinations and delusions
- It can improve clarity of thinking
- It may help stabilize emotional responses
Because it releases slowly, it avoids the peaks and crashes that can sometimes happen with daily pills.
Why Long-Acting Injections Like Uzedy Matter
For many people, one of the biggest challenges in managing schizophrenia is consistency.
Missing doses can lead to:
- Symptom return
- Increased distress
- Hospitalization in some cases
Long-acting medications like Uzedy help by:
- Removing the need to remember daily medication
- Providing steady therapeutic levels
- Supporting long-term stability
What Uzedy Is Not
Because of how it’s being searched online, it’s important to clarify:
- Uzedy is not a recreational or street drug
- It is not a synthetic opioid
- It is not something used for getting high
It is a clinically prescribed treatment used under medical supervision.
Side Effects and Considerations
Like any medication, Uzedy can have side effects. These may include:
- Drowsiness or fatigue
- Weight changes
- Restlessness
- Injection site reactions
- Changes in metabolism
In some cases, people may also experience:
- Emotional flattening
- Brain fog
- Movement-related symptoms
This is why medication management is important. Treatment should always be monitored and adjusted based on how someone feels, not just symptom reduction alone.
The Mental Health Perspective
Medication like Uzedy is often one part of a larger treatment plan.
At Montare, the focus is on:
- Understanding the full picture of someone’s mental health
- Addressing underlying trauma, stress, or emotional patterns
- Supporting long-term stability, not just symptom suppression
Medication can help create stability, but real progress often comes from combining it with therapy and supportive care.
When to Talk to a Professional
If you or someone you care about is:
- Struggling with symptoms like hallucinations or disorganized thinking
- Having difficulty staying consistent with medication
- Experiencing side effects that feel overwhelming
It may be time to explore options with a provider.
Frequently Asked Questions About Uzedy
What is Uzedy injection used for?
Uzedy is used to treat schizophrenia in adults. It’s a long-acting injectable form of risperidone that helps manage symptoms like hallucinations, delusions, and disorganized thinking. Because it releases slowly over time, it can help people stay consistent with treatment without needing to take a daily pill.
Why take risperidone at night?
Risperidone is often taken at night because it can cause drowsiness or sedation. Taking it in the evening can help reduce daytime fatigue and make it easier to tolerate. However, the timing can vary depending on how someone responds, so it should always follow a provider’s guidance.
Is risperidone a controlled substance?
Risperidone is not a controlled substance. It is a prescription medication, but it does not have the same regulatory classification as substances with abuse potential. It’s used under medical supervision to support mental health stability.
Does risperidone cause weight gain?
Yes, risperidone can cause weight gain in some people. This can happen due to changes in appetite, metabolism, and how the body processes energy. Not everyone experiences this, but it’s something providers usually monitor over time.
What is the lowest dose of risperidone?
The lowest starting dose of risperidone is typically around 0.25 mg to 0.5 mg per day, depending on the condition being treated and the individual. Dosing is usually adjusted gradually based on response and tolerability.
Does risperidone make you sleepy?
Yes, risperidone can make you feel sleepy or fatigued, especially when first starting it or after a dose increase. For many people, this effect becomes more manageable over time.
How long does risperidone take to kick in?
Some effects, like calming agitation or improving sleep, may be noticed within a few days. However, the full therapeutic effects, especially for symptoms like hallucinations or disorganized thinking, can take a few weeks to become more noticeable.
Sources
- U.S. Food and Drug Administration. (2023). UZEDY (risperidone) extended-release injectable suspension: Prescribing information. https://www.accessdata.fda.gov/drugsatfda_docs/label/2023/213586s000lbl.pdf
- Teva Pharmaceuticals & MedinCell. (2023, April 28). Teva and MedinCell announce FDA approval of UZEDY (risperidone) extended-release injectable suspension for the treatment of schizophrenia in adults [Press release]. https://ir.tevapharm.com/news-and-events/press-releases/press-release-details/2023/Teva-and-MedinCell-Announce-FDA-Approval-of-UZEDY-risperidone-Extended-Release-Injectable-Suspension-a-Long-Acting-Subcutaneous-Atypical-Antipsychotic-Injection-for-the-Treatment-of-Schizophrenia-in-Adults/default.aspx
- Teva Pharmaceuticals & MedinCell. (2025, October 10). FDA approves expanded indication for UZEDY (risperidone) extended-release injectable suspension as a treatment for adults living with bipolar I disorder [Press release]. https://ir.tevapharm.com/news-and-events/press-releases/press-release-details/2025/FDA-Approves-Expanded-Indication-for-UZEDY-risperidone-Extended-Release-Injectable-Suspension-as-a-Treatment-for-Adults-Living-with-Bipolar-I-Disorder/default.aspx
- How Uzedy Works in the Brain (Risperidone Mechanism of Action)
- Edinoff, A. N., Nix, C. A., Hollier, J., Sagrera, C. E., Delacroix, B. M., Abubakar, T., Cornett, E. M., Kaye, A. M., & Kaye, A. D. (2021). Risperidone. StatPearls. National Center for Biotechnology Information. https://www.ncbi.nlm.nih.gov/books/NBK459313/
- Zhu, Y., Chen, R., Ma, Y., Yang, Y., Zhao, Z., Liu, H., Qin, W., & Li, C. (2025). MRI-based insights into brain structural and functional alterations in schizophrenia treated with risperidone. Frontiers in Psychiatry, 16. https://pmc.ncbi.nlm.nih.gov/articles/PMC12226545/
- Zhornitsky, S., & Stip, E. (2012). Oral versus long-acting injectable antipsychotics in the treatment of schizophrenia and special populations at risk for treatment nonadherence: A systematic review. Schizophrenia Research and Treatment, 2012, 407171. https://pmc.ncbi.nlm.nih.gov/articles/PMC3420640/
- Brissos, S., Veguilla, M. R., Taylor, D., & Balanzá-Martinez, V. (2014). The role of long-acting injectable antipsychotics in schizophrenia: A critical appraisal. Therapeutic Advances in Psychopharmacology, 4(5), 198–219. https://pmc.ncbi.nlm.nih.gov/articles/PMC4212490/
- Zhu, Y., Li, C., & Huhn, M. (2013). Impact of long-acting injectable antipsychotics on medication adherence and clinical, functional, and economic outcomes of schizophrenia. Patient Preference and Adherence, 7, 1171–1184. https://pmc.ncbi.nlm.nih.gov/articles/PMC3833623/
- Teva Pharmaceuticals. (2023). UZEDY (risperidone) extended-release injectable suspension significantly prolongs time to schizophrenia relapse. https://www.tevapharm.com/news-and-media/latest-news/uzedy-risperidone-extended-release-injectable-suspension-significantly-prolongs-time-to-schizophrenia-/
- Veterans Affairs Pharmacy Benefits Management Services. (2023, November). Risperidone SC 1–2 month (UZEDY) national drug monograph. U.S. Department of Veterans Affairs. https://www.va.gov/formularyadvisor/DOC_PDF/MON_Risperidone_UZEDY_Monograph_Nov_2023.pdf